Albuminuria and the ACR Urine Test: An Early Marker of Kidney Damage

The kidney glomerular filter has three layers: capillary endothelium covered with a glycocalyx layer, the basement membrane, and cells called podocytes that form slit diaphragms. This barrier lets water and small molecules through and holds back most plasma proteins. Albumin is small but negatively charged, so it is additionally repelled by the charges of the filtration barrier. A healthy glomerulus lets through only traces, much of which is then taken back up in the proximal tubules.

When the barrier is damaged (for example by chronically raised pressure in the glomerulus, excess glucose and glycation products in diabetes, inflammation or abnormal immune complexes), albumin leaks in larger amounts than the tubules can reabsorb. This is why albuminuria is not only a kidney marker but also an endothelial one: it reflects the general 'tightness' of blood vessels, which explains its link with heart and vascular disease.

Why is the ACR divided by creatinine? Because the albumin concentration in a single sample depends on how diluted the urine is. After drinking a lot of water the urine is pale and every concentration is low; after dehydration the opposite is true. Creatinine is excreted in urine at an approximately constant rate over 24 hours, so the albumin-to-creatinine ratio corrects for dilution and replaces the cumbersome, error-prone 24-hour collection. That approach has a limitation, though: creatinine excretion depends on muscle mass, age and sex, as discussed below.

The division into categories is conventional and useful in practice, but risk does not change abruptly at 30 mg/g. This was shown by a meta-analysis by the CKD Prognosis Consortium of more than 100,000 people from the general population.

In other words, an ACR of 15 mg/g is 'normal' but is statistically associated with slightly higher risk than an ACR of 5 mg/g, and an ACR of 300 mg/g with substantially higher risk. A result in the A1 range therefore does not excuse you from looking after your blood pressure and glycaemia, and an A2 result is not a verdict, just a signal to act.

Dipsticks in a routine urinalysis detect protein only when its concentration is already quite high, and they react mainly to albumin. They can therefore miss category A2, which is exactly the early stage where intervention makes the most sense. The ACR is much more sensitive. Another alternative is the protein-to-creatinine ratio (PCR/UPCR), which covers all proteins, not only albumin. Is it better?

In practice the ACR is therefore the recommended first-choice test in at-risk people, and the protein-to-creatinine ratio is sometimes a supplement when glomerular disease or proteins other than albumin are suspected (for example light chains in myeloma). Those are decisions for the doctor, not for self-interpretation.

The recommended material is usually a first-morning midstream sample (the first void after waking), because it is the most reproducible and the least dependent on daytime activity. If that is not possible, a random sample is accepted, but variability rises. An expert report from the NKDEP-IFCC group notes that patient preparation and time of collection are not standardised, and that methods for measuring urine albumin and creatinine differ between laboratories, so follow-up tests are best done in the same laboratory.

Many people get a 'borderline' ACR after an ordinary training week and worry needlessly. Albuminuria can be transient. The best documented cause is physical exertion. A review by Poortmans and Vanderstraeten indicates that post-exercise proteinuria is related to the intensity of exercise rather than its duration, is a transient state with a decay half-time of about one hour, and results from increased glomerular permeability and partial inhibition of tubular reabsorption. The phenomenon also depends on age.

The key rule is that a single result does not make a diagnosis. According to the 2024 KDIGO guideline, persistent albuminuria is diagnosed when it persists on repeated tests, most often in at least two of three samples over a few months.

The ACR is not routinely done in everyone today, although many specialists call for wider use. Guidelines direct it mainly to people at risk: those with diabetes, hypertension, cardiovascular disease, obesity, a family history of kidney disease or an earlier episode of acute kidney injury. The doctor sets the frequency according to risk category; with a normal result in someone with diabetes, usually every year.

The first step is to confirm the result and establish whether a transient factor is involved. If the albuminuria persists, the doctor usually orders eGFR, a general urine test with sediment, glucose and HbA1c, a blood pressure measurement and an assessment of cardiovascular risk, and sometimes a kidney ultrasound. Treatment depends on the cause: control of blood pressure and glycaemia and, in selected people, drugs that protect the kidneys and heart (for example ACE inhibitors or sartans, SGLT2 inhibitors); whether to use them is for the doctor to decide, not the patient.

Limitations: the evidence in this article comes from observational studies in large cohorts; it indicates an association and does not prove that lowering albuminuria alone improves prognosis in a given person. The A1-A3 boundaries are conventional, and the ACR depends on muscle mass, age, sex and the measurement method. There is no single 'ideal' level for everyone: interpretation depends on eGFR, blood pressure, glycaemia and coexisting conditions, so discuss the result with a doctor rather than relying only on a table from the internet.

If we had to name one underrated test for people with diabetes, hypertension or obesity, it would be the ACR. It costs little, is non-invasive, and gives information about the kidneys and blood vessels that neither creatinine nor eGFR can replace. Remember its variability, though: collect a morning sample, do not train to failure the day before, do not test during an infection, and repeat raised results before drawing conclusions.